PPD’s $1.37 Billion Secondary Offering

Simpson Thacher represented PPD, Inc. (“PPD”) and entities affiliated with Hellman & Friedman LLC (“H&F”) in a secondary offering of common stock of PPD by H&F and other selling stockholders.

The offering consisted of 43,700,000 shares of PPD’s common stock raised approximately $1.37 billion in gross proceeds, with the selling stockholders receiving all of the proceeds from the offering.

PPD is a leading global contract research organization and has been in the drug development business for more than 30 years. PPD provides comprehensive, integrated clinical development and laboratory services to companies and other participants in the biopharmaceutical industry.

The Simpson Thacher team included William Brentani (Picture), Luis R. Pellerano, Anna LeGrett and Michaela Dion (Capital Markets); and Jonathan Cantor and Abigail Hopper (Tax).

Involved fees earner: William Brentani – Simpson Thacher & Bartlett; Jonathan Cantor – Simpson Thacher & Bartlett; Michaela Dion – Simpson Thacher & Bartlett; Abigail Hopper – Simpson Thacher & Bartlett; Anna LeGrett – Simpson Thacher & Bartlett; Luis Pellerano – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Hellman & Friedman; Pharmaceutical Product Development;

Author: Ambrogio Visconti